CAR-T Center: Institute of Hematology & Blood Diseases Hospital
IHCAMS is a top ranked hematology hosptial in China providing world-class hematology care.
Overview of IHCAMS
The Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS) is a world-class center in China dedicated to the diagnosis and treatment of hematologic disorders, including leukemia, lymphoma, and multiple myeloma. With cutting-edge research and innovative therapies, IHCAMS bridges clinical care and translational medicine, providing international patients with access to advanced treatments.
Specialties
The IHCAMS specializes in the diagnosis and treatment of a wide range of blood disorders, including leukemia, lymphoma, multiple myeloma, bone marrow failure, and rare hematologic diseases. The institute offers advanced therapies such as autologous and allogeneic stem cell transplantation, cellular immunotherapy including CAR-T therapy, targeted therapy, and precision medicine guided by molecular and genomic profiling. With a strong focus on clinical research and cutting-edge clinical trials, IHCAMS combines world-class expertise with personalized care to provide innovative, patient-centered treatment for both domestic and international patients.
- CAR-T Therapy Expertise
- Hematopoietic Stem Cell Transplantation
- Advanced Hematology Diagnostics
- Multidisciplinary Treatment Teams
- International Medical Collaboration
- Modern Facilities & Advanced Technology
What Did Patients Say
Hear directly from patients about their experiences and outcomes at IHCAMS, especially with CAR-T therapy and personalized hematologic care.
“After being diagnosed with multiple myeloma, I was nervous about traveling for treatment. The team at IHCAMS made everything seamless—from consultation to CAR-T therapy. The doctors were highly skilled, and I felt cared for every step of the way. My condition has improved significantly, and I am grateful for the expertise and support I received.”
Maria, Multiple Myeloma
Colombia
Frequently Asked Questions
This FAQ section answers common questions about treatment options, CAR-T therapy, and the care process at IHCAMS help international patients better understand their medical journey.
1. What CAR-T therapies are offered at IHCAMS?
The hospital provides CAR-T treatment for relapsed or refractory leukemia, lymphoma, and multiple myeloma, using personalized protocols based on each patient’s condition.
2. Who is eligible for CAR-T therapy at IHCAMS?
Patients with specific blood cancers, including adults and children with relapsed or refractory disease, are assessed by the hospital’s expert team to determine eligibility.
3. Can international patients receive treatment at IHCAMS
Absolutely. IHCAMS supports international patients with medical consultations, biomarker testing, treatment planning, visa and travel assistance, and multilingual guidance throughout care.
4. How does IHCAMS support CAR-T patients?
5. What types of stem cell transplantation are available?
6. How do I contact IHCAMS for treatment information?
Get In Touch
Meet The Experts
Dr. QIU Lugui
Hematologist
Dr. AN Gang
Hematologist
Dr. ZOU Dehui
Hematologist
